- Sector
- Healthcare
- Industry
- Medical Devices
Highlights
- Year Range
- $0.04 - $0.16
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZOMDF Performance Chart
Zomedica Corp (ZOMDF) is down 27.3% since the beginning of the year. At $0 per share, ZOMDF is trading 53.2% below its 52-week high of $0. Investors who bought $1,000 worth of ZOMDF shares 5 years ago would now be looking at an investment worth $87.
Loading charts...
Returns By Period
Zomedica Corp (ZOMDF) has returned -27.27% so far this year and 78.31% over the past 12 months.
Zomedica Corp
- 1D
- -3.90%
- 1M
- -29.12%
- YTD
- -27.27%
- 6M
- -32.11%
- 1Y
- 78.31%
- 3Y*
- -27.90%
- 5Y*
- -38.59%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ZOMDF Monthly Returns History
Based on dividend-adjusted daily data since Jul 29, 2016, ZOMDF's average daily return is +0.12%, while the average monthly return is +2.32%. At this rate, an investment would double in approximately 2.5 years.
Historically, 43% of months were positive and 58% were negative. The best month was Jan 2021 with a return of +299.0%, while the worst month was Mar 2019 at -66.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, ZOMDF closed higher 41% of trading days. The best single day was Jan 11, 2021 with a return of +92.2%, while the worst single day was Mar 5, 2025 at -50.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 23.93% | 4.04% | -8.99% | -20.84% | 8.59% | -27.90% | -27.27% | ||||||
| 2025 | 2.42% | -11.80% | -46.49% | -3.02% | -14.67% | -15.73% | -3.83% | 13.11% | 79.32% | -3.68% | 53.95% | -13.03% | -15.21% |
| 2024 | -33.12% | 6.80% | 2.03% | -2.60% | 17.31% | -12.30% | 2.60% | -14.07% | 6.44% | -12.39% | 6.49% | -6.25% | -40.06% |
| 2023 | 69.14% | -12.84% | -11.90% | -5.34% | -1.20% | 1.01% | 5.00% | -11.90% | -9.68% | 0.54% | -0.00% | 19.17% | 22.82% |
| 2022 | 1.57% | 15.68% | -6.41% | -26.71% | -5.30% | -5.90% | 17.26% | -5.39% | -13.60% | 8.91% | -12.97% | -18.50% | -46.82% |
| 2021 | 298.96% | 103.26% | -15.51% | -32.91% | -20.75% | -0.87% | -26.94% | 4.83% | -17.92% | -2.50% | -22.47% | -22.54% | 32.91% |
Benchmark Metrics
Zomedica Corp has an annualized alpha of 19.81%, beta of 0.92, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since July 29, 2016.
- This stock participated in 145.53% of S&P 500 Index downside but only 4.10% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 19.81%
- Beta
- 0.92
- R²
- 0.02
- Upside Capture
- 4.10%
- Downside Capture
- 145.53%
Return for Risk
Risk / Return Rank
ZOMDF ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zomedica Corp (ZOMDF) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZOMDF | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.89 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.37 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | 2.78 | -1.27 |
| Martin ratioReturn relative to average drawdown | 3.33 | 12.44 | -9.11 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zomedica Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zomedica Corp was 98.99%, occurring on Mar 7, 2025. The portfolio has not yet recovered.
The current Zomedica Corp drawdown is 97.52%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -98.99%Mar 2025 | 6y 8mo | — | 8y 17hJun 2018 - now |
2018 bear market2018 | -29.40%Jun 2018 | 9mo 6d | 7d | 9mo 13dSep 2017 - Jun 2018 |
2016 bear market2016 | -27.03%Dec 2016 | 1mo 24d | 4mo 6d | 6moOct 2016 - Apr 2017 |
2017 correction2017 | -19.17%Apr 2017 | 3d | 21d | 24dApr 2017 - May 2017 |
2017 correction2017 | -15.54%Jun 2017 | 15d | 1mo 16d | 2mo 1dMay 2017 - Jul 2017 |
Drawdown Indicators
| ZOMDF | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.99% | -56.78% | -42.21% |
Max Drawdown (1Y)Largest decline over 1 year | -51.95% | -9.10% | -42.85% |
Max Drawdown (3Y)Largest decline over 3 years | -86.96% | -18.90% | -68.06% |
Max Drawdown (5Y)Largest decline over 5 years | -96.61% | -25.43% | -71.18% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.52% | -1.80% | -95.72% |
Average DrawdownAverage peak-to-trough decline | -72.37% | -10.71% | -61.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.58% | 2.03% | +21.55% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zomedica Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zomedica Corp is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZOMDF
Add Zomedica Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZOMDF